- Home
- NEN vs VOR Comparison
NEN vs VOR Comparison
Compare NEN & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEN
- VOR
- Stock Information
- Founded
- NEN 1977
- VOR 2015
- Country
- NEN United States
- VOR United States
- Employees
- NEN N/A
- VOR N/A
- Industry
- NEN Building operators
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- NEN Real Estate
- VOR Health Care
- Exchange
- NEN Nasdaq
- VOR Nasdaq
- Market Cap
- NEN 239.3M
- VOR 207.1M
- IPO Year
- NEN N/A
- VOR 2021
- Fundamental
- Price
- NEN $67.00
- VOR $7.98
- Analyst Decision
- NEN
- VOR Buy
- Analyst Count
- NEN 0
- VOR 7
- Target Price
- NEN N/A
- VOR $70.43
- AVG Volume (30 Days)
- NEN 3.3K
- VOR 1.0M
- Earning Date
- NEN 01-01-0001
- VOR 11-13-2025
- Dividend Yield
- NEN 7.21%
- VOR N/A
- EPS Growth
- NEN N/A
- VOR N/A
- EPS
- NEN 3.33
- VOR N/A
- Revenue
- NEN $87,362,592.00
- VOR N/A
- Revenue This Year
- NEN N/A
- VOR N/A
- Revenue Next Year
- NEN N/A
- VOR N/A
- P/E Ratio
- NEN $20.02
- VOR N/A
- Revenue Growth
- NEN 7.63
- VOR N/A
- 52 Week Low
- NEN $66.00
- VOR $2.62
- 52 Week High
- NEN $84.00
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- NEN 36.51
- VOR 24.79
- Support Level
- NEN $66.00
- VOR $6.50
- Resistance Level
- NEN $71.07
- VOR $8.77
- Average True Range (ATR)
- NEN 0.92
- VOR 1.06
- MACD
- NEN -0.25
- VOR -0.21
- Stochastic Oscillator
- NEN 24.65
- VOR 10.63
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.